This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: TXN HAL DFS CELG THOR

Texas Instruments (TXN - Get Report) downgraded at Pacific Crest. Estimates also cut, given an expected inventory correction.

STOCK COMMENTS / EPS CHANGES

Celgene (CELG - Get Report) target raised at Jefferies to $91, Jefferies said. Positive topline data for Abraxane. Buy rating.

Chemed Corporation (CHE) target raised at Oppenheimer to $80, Oppenheimer said. Bullish following management meetings. Outperform rating.

CNO Financial (CNO) cut from Conviction Buy List at Goldman. Valuation call, as the stock is up 41% since June. $11 price target.

Express (EXPR) estimates, target reduced at BMO. Shares of EXPR now seen reaching $15, according to BMO Capital. Estimates also cut, given the company's new guidance. Outperform rating.

Halliburton (HAL) numbers lowered at Jefferies. Shares of HAL now seen reaching $44, Jefferies said. Estimates also lowered on North America weakness. Buy rating.

Helmerich & Payne (HP) numbers lowered at Jefferies. Shares of HP now seen reaching $55, Jefferies said. Estimates also lowered on North American weakness. Buy rating.

Medivation (MDVN) numbers raised at Citigroup. Shares of MDVN now seen reaching $70, Citigroup said. Estimates also increased to reflect higher Xtandi US price. Buy rating.

Mosaic (MOS) numbers cut at Citigroup. Shares of MOS now seen reaching $69, Citigroup said. Estimates also lowered on disappointing quarterly results. Buy rating.

MSCI (MSCI) estimates, target reduced at Credit Suisse. MSCI estimates were cut through 2014, Credit Suisse said. Vanguard loss will cut into profits. Outperform rating and new $31 price target.

AT&T (T) estimates trimmed at UBS through 2012 on higher iPhone sales, UBS said. Neutral rating and $35 price target.

Zillow (Z) estimates, target increased at ThinkEquity. Z estimates were raised through 2013, ThinkEquity said. Strong agent demand will improve pricing power. Buy rating and new $49 price target.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CELG $114.72 -3.37%
DFS $58.67 0.48%
CSX $36.90 -0.59%
TXN $55.56 1.52%
THOR $40.55 -4.20%

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs